Swedish biotech Calliditas has announced plans to file its rare disease drug Nefecon with the FDA early next year following positive results from a phase 3 clinical trial. The company has been ...
Slaying the Hero Valentin is the final hero-slaying quest in Code Vein 2. It might come as a bit of a surprise, but according ...
That revamp was designed to ensure the biotech had resources to deliver three key trial readouts, namely interim data from the phase 2 portion of its antibody-drug conjugate (ADC) MGC018 in prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results